Cargando…
Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes
BACKGROUND: The prevalence, management, and clinical outcomes of cholangiocarcinoma in Africa are unknown. The aim is to conduct a comprehensive systematic review on the epidemiology, management, and outcomes of cholangiocarcinoma in Africa. METHODS: We searched PubMed, EMBASE, Web of Science and CI...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007746/ https://www.ncbi.nlm.nih.gov/pubmed/36906562 http://dx.doi.org/10.1186/s12876-023-02687-6 |
_version_ | 1784905597563437056 |
---|---|
author | Asombang, Akwi W. Chishinga, Nathaniel Mohamed, Mouhand F. Nkhoma, Alick Chipaila, Jackson Nsokolo, Bright Manda-Mapalo, Martha Montiero, Joao Filipe G. Banda, Lewis Dua, Kulwinder S. |
author_facet | Asombang, Akwi W. Chishinga, Nathaniel Mohamed, Mouhand F. Nkhoma, Alick Chipaila, Jackson Nsokolo, Bright Manda-Mapalo, Martha Montiero, Joao Filipe G. Banda, Lewis Dua, Kulwinder S. |
author_sort | Asombang, Akwi W. |
collection | PubMed |
description | BACKGROUND: The prevalence, management, and clinical outcomes of cholangiocarcinoma in Africa are unknown. The aim is to conduct a comprehensive systematic review on the epidemiology, management, and outcomes of cholangiocarcinoma in Africa. METHODS: We searched PubMed, EMBASE, Web of Science and CINHAL from inception up to November 2019 for studies on cholangiocarcinoma in Africa. The results reported follow PRISMA guidelines. Quality of studies and risk of bias were adapted from a standard quality assessment tool. Descriptive data were expressed as numbers with proportions and Chi-squared test was used to compare proportions. P values < 0.05 were considered significant. RESULTS: A total of 201 citations were identified from the four databases. After excluding duplicates, 133 full texts were reviewed for eligibility, and 11 studies were included. The 11 studies are reported from 4 countries only: 8 are from North Africa (Egypt 6 and Tunisia 2), and 3 in Sub-Saharan Africa (2 in South Africa, 1 in Nigeria). Ten studies reported management and outcomes, while one study reported epidemiology and risk factors. Median age for cholangiocarcinoma ranged between 52 and 61 years. Despite the proportion with cholangiocarcinoma being higher among males than females in Egypt, this gender disparity could not be demonstrated in other African countries. Chemotherapy is mainly used for palliative care. Surgical interventions are curative and prevent cancer progression. Statistical analyses were performed with Stata 15.1. CONCLUSION: The known global major risk factors such as primary sclerosing cholangitis, Clonorchis sinensis and Opisthorchis viverrini infestation are rare. Chemotherapy treatment was mainly used for palliative treatment and was reported in three studies. Surgical intervention was described in at least 6 studies as a curative modality of treatment. Diagnostic capabilities such as radiographic imaging and endoscopic are lacking across the continent which most likely plays a role in accurate diagnosis. |
format | Online Article Text |
id | pubmed-10007746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100077462023-03-12 Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes Asombang, Akwi W. Chishinga, Nathaniel Mohamed, Mouhand F. Nkhoma, Alick Chipaila, Jackson Nsokolo, Bright Manda-Mapalo, Martha Montiero, Joao Filipe G. Banda, Lewis Dua, Kulwinder S. BMC Gastroenterol Research Article BACKGROUND: The prevalence, management, and clinical outcomes of cholangiocarcinoma in Africa are unknown. The aim is to conduct a comprehensive systematic review on the epidemiology, management, and outcomes of cholangiocarcinoma in Africa. METHODS: We searched PubMed, EMBASE, Web of Science and CINHAL from inception up to November 2019 for studies on cholangiocarcinoma in Africa. The results reported follow PRISMA guidelines. Quality of studies and risk of bias were adapted from a standard quality assessment tool. Descriptive data were expressed as numbers with proportions and Chi-squared test was used to compare proportions. P values < 0.05 were considered significant. RESULTS: A total of 201 citations were identified from the four databases. After excluding duplicates, 133 full texts were reviewed for eligibility, and 11 studies were included. The 11 studies are reported from 4 countries only: 8 are from North Africa (Egypt 6 and Tunisia 2), and 3 in Sub-Saharan Africa (2 in South Africa, 1 in Nigeria). Ten studies reported management and outcomes, while one study reported epidemiology and risk factors. Median age for cholangiocarcinoma ranged between 52 and 61 years. Despite the proportion with cholangiocarcinoma being higher among males than females in Egypt, this gender disparity could not be demonstrated in other African countries. Chemotherapy is mainly used for palliative care. Surgical interventions are curative and prevent cancer progression. Statistical analyses were performed with Stata 15.1. CONCLUSION: The known global major risk factors such as primary sclerosing cholangitis, Clonorchis sinensis and Opisthorchis viverrini infestation are rare. Chemotherapy treatment was mainly used for palliative treatment and was reported in three studies. Surgical intervention was described in at least 6 studies as a curative modality of treatment. Diagnostic capabilities such as radiographic imaging and endoscopic are lacking across the continent which most likely plays a role in accurate diagnosis. BioMed Central 2023-03-11 /pmc/articles/PMC10007746/ /pubmed/36906562 http://dx.doi.org/10.1186/s12876-023-02687-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Asombang, Akwi W. Chishinga, Nathaniel Mohamed, Mouhand F. Nkhoma, Alick Chipaila, Jackson Nsokolo, Bright Manda-Mapalo, Martha Montiero, Joao Filipe G. Banda, Lewis Dua, Kulwinder S. Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes |
title | Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes |
title_full | Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes |
title_fullStr | Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes |
title_full_unstemmed | Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes |
title_short | Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes |
title_sort | systematic review of cholangiocarcinoma in africa: epidemiology, management, and clinical outcomes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007746/ https://www.ncbi.nlm.nih.gov/pubmed/36906562 http://dx.doi.org/10.1186/s12876-023-02687-6 |
work_keys_str_mv | AT asombangakwiw systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT chishinganathaniel systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT mohamedmouhandf systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT nkhomaalick systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT chipailajackson systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT nsokolobright systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT mandamapalomartha systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT montierojoaofilipeg systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT bandalewis systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes AT duakulwinders systematicreviewofcholangiocarcinomainafricaepidemiologymanagementandclinicaloutcomes |